AMETEK (NYSE:AME) Updates Q1 2026 Earnings Guidance

AMETEK (NYSE:AME) updated its first quarter 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 1.850-1.900 for the period, compared to the consensus estimate of 1.900. The company issued revenue guidance of $1.9 billion-$1.9 billion, compared to the consensus revenue estimate of $1.9 billion. AMETEK also updated its FY 2026 guidance to 7.870-8.070 EPS.

AMETEK Trading Up 0.4%

AMETEK stock opened at $228.68 on Wednesday. The company has a debt-to-equity ratio of 0.14, a quick ratio of 0.72 and a current ratio of 1.16. AMETEK has a fifty-two week low of $145.02 and a fifty-two week high of $233.17. The stock has a market cap of $52.64 billion, a P/E ratio of 36.07, a PEG ratio of 3.10 and a beta of 1.03. The firm’s fifty day moving average price is $209.02 and its 200-day moving average price is $194.83.

AMETEK (NYSE:AME) last posted its earnings results on Tuesday, February 3rd. The technology company reported $2.01 EPS for the quarter, topping the consensus estimate of $1.94 by $0.07. The business had revenue of $2 billion during the quarter, compared to analysts’ expectations of $1.94 billion. AMETEK had a return on equity of 16.66% and a net margin of 20.50%.The firm’s revenue was up 13.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.87 earnings per share. AMETEK has set its Q1 2026 guidance at 1.850-1.900 EPS and its FY 2026 guidance at 7.870-8.070 EPS. Equities research analysts forecast that AMETEK will post 7.15 earnings per share for the current fiscal year.

AMETEK Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 19th. Investors of record on Friday, December 5th were paid a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend was Friday, December 5th. AMETEK’s dividend payout ratio (DPR) is currently 19.56%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on AME shares. KeyCorp boosted their price target on shares of AMETEK from $220.00 to $235.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 6th. Melius Research set a $235.00 target price on AMETEK in a research note on Monday, January 5th. Oppenheimer downgraded AMETEK from an “outperform” rating to a “market perform” rating in a research report on Tuesday, January 27th. Wall Street Zen upgraded AMETEK from a “hold” rating to a “buy” rating in a report on Saturday, November 1st. Finally, Barclays set a $220.00 price objective on AMETEK in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $230.73.

Insider Activity

In related news, VP Thomas M. Montgomery sold 6,388 shares of the company’s stock in a transaction on Monday, December 22nd. The shares were sold at an average price of $205.05, for a total transaction of $1,309,859.40. Following the completion of the sale, the vice president directly owned 22,116 shares in the company, valued at $4,534,885.80. This represents a 22.41% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Thomas C. Marecic sold 14,310 shares of the business’s stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $202.11, for a total transaction of $2,892,194.10. Following the completion of the transaction, the insider owned 42,589 shares in the company, valued at $8,607,662.79. The trade was a 25.15% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 137,088 shares of company stock valued at $27,212,340. 0.57% of the stock is currently owned by company insiders.

Trending Headlines about AMETEK

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: AMETEK reported beat-and-raise results: Q4 EPS $2.01 vs. $1.94 expected and revenue of $2.0B vs. $1.94B expected, with revenue up ~13.4% year‑over‑year — the core reason the stock is moving up after the print. AMETEK Announces Record Fourth Quarter and Full Year Results
• Positive Sentiment: Management reiterated a confident outlook for 2026 even while providing a range — that continued confidence plus strong margins (net margin ~20.5%) supports investor sentiment. AMETEK Delivers Record 2025 Results and Confident 2026 Outlook
• Neutral Sentiment: AMETEK completed a strategic tuck‑in acquisition of LKC Technologies (ophthalmic diagnostics) — accretive for specialized medical instrumentation but not a material near‑term revenue driver. AMETEK Acquires LKC Technologies
• Neutral Sentiment: The full earnings call transcript and multiple analyst recaps are available for details on segment performance and margin drivers — useful for investors digging into guidance assumptions. AMETEK, Inc. (AME) Q4 2025 Earnings Call Transcript
• Negative Sentiment: FY 2026 guidance came in at EPS 7.870–8.070 (street ~8.00) and Q1 guide 1.850–1.900 (slightly under consensus), which trimmed upside and prompted caution among some investors. AMETEK Earnings Release and Guidance
• Negative Sentiment: Management flagged tariff/POE (policy/ tariff) uncertainty as a factor that could pressure 2026 profit expectations — a headline risk investors are watching. AMETEK forecasts 2026 profit below estimates on tariff uncertainty
• Negative Sentiment: Some sell‑side and market commentary reflects valuation concerns: Morgan Stanley kept a Hold with a $215 PT, and independent pieces warn AMETEK’s premium multiple could invite downgrades if growth slows. These views cap near‑term multiple expansion. Resilient Revenue and Margin Caution Keep Ametek at Hold
• Negative Sentiment: Institutional trimming and critical commentary (e.g., Giverny Capital selling down exposure and a Seeking Alpha piece calling valuation a risk) add selling pressure for investors prioritizing valuation. Giverny Capital Asset Management Trimmed Ametek (AME) on Valuation AMETEK: Perilously Close To A Downgrade As Valuation Outweighs Fantastic Growth

Institutional Trading of AMETEK

Several large investors have recently added to or reduced their stakes in AME. Lazard Asset Management LLC lifted its position in shares of AMETEK by 35.7% in the 3rd quarter. Lazard Asset Management LLC now owns 2,645,977 shares of the technology company’s stock worth $497,444,000 after purchasing an additional 695,419 shares during the period. Man Group plc lifted its holdings in AMETEK by 411.8% in the third quarter. Man Group plc now owns 785,020 shares of the technology company’s stock worth $147,584,000 after buying an additional 631,649 shares during the period. AQR Capital Management LLC boosted its position in AMETEK by 343.5% during the 2nd quarter. AQR Capital Management LLC now owns 656,112 shares of the technology company’s stock valued at $118,349,000 after acquiring an additional 508,164 shares in the last quarter. Millennium Management LLC grew its holdings in shares of AMETEK by 109.3% during the 3rd quarter. Millennium Management LLC now owns 845,346 shares of the technology company’s stock worth $158,925,000 after acquiring an additional 441,365 shares during the period. Finally, Freestone Grove Partners LP lifted its stake in shares of AMETEK by 116.0% in the 3rd quarter. Freestone Grove Partners LP now owns 476,035 shares of the technology company’s stock valued at $89,495,000 after purchasing an additional 255,641 shares during the period. Institutional investors own 87.43% of the company’s stock.

About AMETEK

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.